Cleerly ISCHEMIA vs Stethee Pro 1
AI Verdict
Choose Cleerly ISCHEMIA if…
Choose Cleerly ISCHEMIA if you require a comprehensive, non-invasive assessment of coronary artery disease, including detailed plaque characterization and vessel-level ischemia likelihood, derived from CCTA scans. This tool is ideal for physicians needing precise anatomical and functional insights to guide personalized diagnosis and treatment planning for heart disease.
View Cleerly ISCHEMIA →Choose Stethee Pro 1 if…
Choose Stethee Pro 1 if you need real-time, AI-enabled auscultation and vital sign analysis for cardiac and respiratory conditions, especially in point-of-care or remote monitoring scenarios. This wireless digital stethoscope system is best suited for quick diagnostic insights, telemedicine, and secure sharing of heart and lung sounds.
View Stethee Pro 1 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly ISCHEMIA | Stethee Pro 1 |
|---|---|---|
| Pricing | Unknown | $499 usd |
| Deployment | Web-based solution | Cloud, Mobile |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Stethee Pro 1Stethee Pro 1 offers a more immediate and intuitive user experience due to its physical wireless device, mobile application, and real-time feedback capabilities for direct patient interaction and data capture. Cleerly ISCHEMIA, while providing comprehensive web-based reports, operates within a more specialized diagnostic workflow focused on post-scan analysis. User reviews for Stethee Pro 1 often highlight its ease of use and convenience.
Clinical Value
Cleerly ISCHEMIACleerly ISCHEMIA provides advanced AI analysis of CCTA scans to non-invasively determine ischemia likelihood, estimate FFR, and characterize coronary plaque, addressing a complex and critical diagnostic pathway in cardiology. This has the potential to guide more precise and less invasive treatment decisions for coronary artery disease. Stethee Pro 1 enhances traditional auscultation with digital and AI capabilities, which is valuable, but Cleerly's impact on high-level diagnostic and treatment planning for a life-threatening condition is arguably greater.
Pricing & Value
Stethee Pro 1Stethee Pro 1 offers transparent pricing for its core device ($499), allowing for a clearer initial understanding of the investment, even though the subscription cost for the web portal is not detailed. Cleerly ISCHEMIA's pricing is entirely opaque, stating 'contact for details' and 'varies by provider,' which makes it difficult for potential users to assess its value proposition without direct engagement.
Enterprise Readiness
Cleerly ISCHEMIACleerly ISCHEMIA explicitly confirms a Business Associate Agreement (BAA) and details enterprise-grade deployment methods such as data transfer via VPN or virtual appliance (Cleerly Proxy), along with integration with PowerScribe via API. These features demonstrate a comprehensive approach to enterprise deployment, data security, and workflow integration. While Stethee Pro 1 is HIPAA compliant and 'likely' has a BAA, its enterprise integration details are less specific.
Innovation
TieBoth tools demonstrate significant innovation. Cleerly ISCHEMIA applies advanced AI to complex CCTA imaging data for non-invasive FFR estimation and detailed plaque characterization, pushing the boundaries of cardiac diagnostic imaging. Stethee Pro 1 innovatively transforms a traditional stethoscope into an AI-enabled, wireless, digital system with real-time analysis, advanced amplification, and environmental data tagging, redefining a fundamental diagnostic tool.
Support & Docs
Stethee Pro 1M3DICINE's website for Stethee Pro 1 explicitly features a dedicated 'Support' section with readily accessible FAQs and user manuals, indicating a transparent and immediate approach to user documentation. While Cleerly's website mentions a 'Support' section and 'Cleerly University' for education, the direct availability of specific user manuals and FAQs for Stethee Pro 1 suggests a more robust and easily discoverable self-service support offering.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly ISCHEMIA | Stethee Pro 1 |
|---|---|---|
| Name | Cleerly ISCHEMIA | Stethee Pro 1 |
| Company | Cleerly | M3DICINE Pty Ltd. |
| Tagline | AI-Powered Precision for Non-Invasive Ischemia Detection | The World's First AI-Enabled Wireless Stethoscope System for Advanced Cardiac and Respiratory Diagnostics. |
| Primary Function | Analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level. | AI-enabled wireless digital stethoscope system providing real-time cardiac and respiratory vital sign analysis. |
| Key Feature Example 1 | AI-enabled CCTA analysis | AI-enabled wireless digital stethoscope system |
| Key Feature Example 2 | Non-invasive fractional flow reserve (FFR) estimation | Captures cardiac and respiratory vital signs in 20 seconds |
Videos
Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and Stethee Pro 1.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly ISCHEMIA or Stethee Pro 1
Backers
Who funded each tool's parent company.